← Eichor
Condition: Blood And Marrow Transplantation Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Blood And Marrow Transplantation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Activity Levels in Bone Marrow Transplant Patients
Phase N/A · 1 location(s) · Michael Tomasson · NCT04115241A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Ce
Phase 1 · 21 location(s) · TScan Therapeutics, Inc. · NCT05473910Methods of T Cell Depletion Trial (MoTD)
Phase 2 · 17 location(s) · University of Birmingham · NCT04888741Haplo-Cord HSCT for AML/MDS
NA · 4 location(s) · Fujian Medical University Union Hospital · NCT07588360The HOPE Biobank Resource (BMT CTN 2402 HOPE)
Phase N/A · 6 location(s) · Medical College of Wisconsin · NCT07227155Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02438904Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Foll
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05470491Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07297576Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilic
Phase 1/Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03173937Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03314974Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT06856226High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Phase N/A · 1 location(s) · Yigeng Cao,MD,PhD · NCT07205523Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation
Phase N/A · 1 location(s) · Stanford University · NCT01629017A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patie
Phase 2 · 13 location(s) · Center for International Blood and Marrow Transplant Researc · NCT06859424Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Mosaic Trial for Stem Cell Transplant Recipients
NA · 3 location(s) · Northwestern University · NCT06960993Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-inten
Phase 2 · 10 location(s) · University of Liege · NCT03852407Rehab Study for alloBMT Patients
NA · 1 location(s) · Jennifer Jones · NCT07457866CIBMTR Research Database
Phase N/A · 2 location(s) · Center for International Blood and Marrow Transplant Researc · NCT01166009Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells a
Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03520647Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
EARLY_Phase 1 · 1 location(s) · Omar Aljitawi · NCT03964506ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
Phase 2 · 1 location(s) · Leland Metheny · NCT06680661National Longitudinal Cohort of Hematological Diseases
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04645199Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT06904482Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease
Phase N/A · 1 location(s) · Anhui Provincial Hospital · NCT05823376Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (
Phase 2 · 1 location(s) · Hannah Choe, MD · NCT07249346CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT06787560A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transpl
Phase 3 · 26 location(s) · TScan Therapeutics, Inc. · NCT07702578A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.
Phase 1/Phase 2 · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT07301866Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT01861106
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.